Sponsor content
59 result(s) found, displaying 11 to 20
-
Prescription medicine registrationActive ingredients: cabozantinib (S)-malate.
-
Prescription medicine registrationActive ingredients: odevixibat, odevixibat sesquihydrate.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RELFYDESS relabotulinumtoxinA 100 units/mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 1 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 10 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 1.5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 2.5 mg capsule blister pack.
-
Australian public assessment report (AusPar)Sohonos (palovarotene) was approved to treat heterotopic ossification in individuals with fibrodysplasia ossificans progressiva.